news
  •  
    • First in human study taking place in Dr. Agarwal’s group of eye hospitals and Eye Research Center, Chennai, India. Since its commencement, 110 procedures have been carried out.
    • Post-market study in S.V. Malayan's Eye Center, Yerevan, Armenia. So far, 8 out of 30 patients have undergone the procedure.
    • Multi-center post-market study in India was initiated. It will include 160 patients.
  •  
    • “Minimally Invasive Micro Sclerostomy (MIMS®)” – Invited presentation, Ophthalmology Futures Forum Tokyo, Apr. 1, 2014
    • “Developing a New Surgical Procedure for Glaucoma”, Annual Conference of the Israel Ophthalmology Society, May 14-15, 2014, Tel-Aviv, Israel.
    • "MIMS®: Minimally Invasive Micro Sclerostomy", Emerging Medical Technologies (EMT) Summit, October 20, 2015, San Francisco, U.S.A.
    • "MIMS®: Minimally Invasive Micro Sclerostomy", China Israel Technology Innovation & Investment Summit, January 4-6, 2016, Bejing, China.
    • "MIMS®: Minimally Invasive Micro Sclerostomy", Glaucoma 360 - 5th Annual New Horizons Forum, January 29, 2016, San Francisco, U.S.A
    • "Combined phacoemulsification and minimally invasive microsclerostomy (MIMS® - Sanoculis) procedure in cataract - glaucoma patients - report of short term follow-up in the first 15 cases", Annual Conference on Ocular Microsurgery 2017, January 12, 2017, Eilat, Israel.
    • "MIMS®: Minimal Invasive Micro Sclerotomy for the Treatment of Glaucoma, Annual Conference on Ocular Microsurgery 2018, January 10, 2018, Eilat, Israel.
    • “MIMS® Procedure: Concept and Experimental Models”, American Glaucoma Society 2018 Annual Meeting.
  •  
    • Globes 2015 - High-Tech and Technology Sector, http://wink.globes.co.il/globes/duns100/ht/#66/z, Dec. 30, 2015
    • “Sanoculis: Early-stage Glaucoma Treatment Achieves Pressure Lowering Without an Implant”, The MEDTECH Strategist, Vol. 3, No. 1, Jan. 19, 2016.
    • “Minimally invasive micro Sclerostomy may be alternative to trabeculctomy”, Healio Ocular Surgery News, May 10, 2016
    • “Sanoculis Receives CE Mark for its Minimally Invasive Micro Sclerostomy (MIMS®) Device”, Eyewiretoday, March 17, 2017
  •